Journal of Gastroenterology

, Volume 40, Issue 7, pp 690–697 | Cite as

Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus

  • Hiroshi Yasuda
  • Masaya Yamada
  • Yutaka Endo
  • Kazuaki Inoue
  • Makoto Yoshiba



Duodenogastric reflux after surgery increases the risk of gastric carcinoma. To determine whether bile reflux influences the development of gastric cancer in patients who have not had surgery, we compared cyclooxygenase-2 (COX-2) immunoreactivity in early gastric cancer originating from the gastric pylorus and that originating from other locations. We also examined the effects of bile acids on the expression and activity of COX-2 in gastric cells in vitro.


Tumor sections from 79 patients who underwent endoscopic mucosal resection for early intestinal-type gastric carcinoma were stained using a COX-2-specific monoclonal antibody. Immunoblotting of COX-2 was used to assess the effects of bile acids on COX-2 expression and activity in human gastric cell lines.


Among the 79 early gastric cancer lesions studied, 13 (16%) arose in the gastric pylorus. In this group, COX-2 immunoreactivity was negative to weak in 38% (5 of 13 lesions) and moderate to strong in 62% (8 of 13 lesions). In the control group, COX-2 immunoreactivity was negative to weak in 70% (46 of 66 lesions) and moderate to strong in 30% (20 of 66 lesions). COX-2 expression was significantly elevated in early gastric cancer located in the gastric pylorus, compared with that in the other locations. In human gastric cell lines, bile acids induced COX-2 expression, mediated by the ERK 1/2 mitogen-activated protein kinase pathway.


COX-2 expression is elevated in early gastric cancer of the gastric pylorus, a common site of gastric cancer. Bile acids induced COX-2 expression in human gastric cell lines, suggesting a role of bile reflux in gastric carcinogenesis.

Key words

COX-2 gastric pylorus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tredaniel, J, Boffetta, P, Buiatti, E,  et al. 1997Tobacco smoking and gastric cancer: review and metaanalysisInt J Cancer7256573CrossRefPubMedGoogle Scholar
  2. 2.
    Buiatti, E, Palli, D, Decarli, A,  et al. 1989A case—control study of gastric cancer and diet in ItalyInt J Cancer446116PubMedGoogle Scholar
  3. 3.
    Uemura, N, Okamoto, S, Yamamoto, S,  et al. 2001Helicobacter pylori infection and the development of gastric cancerN Engl J Med3457849PubMedGoogle Scholar
  4. 4.
    Lundegardh, G, Adami, H-O, Helmick, C,  et al. 1988Stomach cancer after partial gastrectomy for benign ulcer diseaseN Engl J Med319195200PubMedGoogle Scholar
  5. 5.
    Miwa, K, Hasegawa, H, Fujimura, T,  et al. 1992Duodenal reflux through the pylorus induces gastric adenocarcinoma in the ratCarcinogenesis1323136PubMedGoogle Scholar
  6. 6.
    Schindlbeck, NE, Heinrich, C, Stellaard, F,  et al. 1987Healthy controls have as much bile reflux as gastric ulcer patientsGut28157783PubMedGoogle Scholar
  7. 7.
    Giardiello, FM, Hamilton, SR, Krush, AJ,  et al. 1993Treatment of colonic and rectal adnomas with sulindac in familial adenomatous polyposisN Engl J Med32813136CrossRefPubMedGoogle Scholar
  8. 8.
    Kune, GA, Kune, S, Watson, LF 1988Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from Melbourne Colorectal Cancer StudyCancer Res484399404PubMedGoogle Scholar
  9. 9.
    Thun, MJ, Namboodiri, MM, Heath, CW,Jr 1991Aspirin use and reduced risk of fatal colon cancerN Engl J Med32515936PubMedGoogle Scholar
  10. 10.
    Kawamori, T, Rao, CV, Seibert, K,  et al. 1998Chemopreventive activity of celecoxib, a specific cyclooxygenease-2 inhibitor, against colon carcinogenesisCancer Res5840912PubMedGoogle Scholar
  11. 11.
    Marnett, LJ, Dubois, RN 2002COX-2: a target for colon cancer preventionAnnu Rev Pharmacol Toxicol425580CrossRefPubMedGoogle Scholar
  12. 12.
    Hinz, B, Brune, K 2002 Cyclooxygenase-2, 10 years laterJ Pharmacol Exp Ther30036775CrossRefPubMedGoogle Scholar
  13. 13.
    Williams, CS, Mann, M, Dubois, RN 1999The role of cyclooxygenases in inflammation, cancer, and developmentOncogene18790816CrossRefPubMedGoogle Scholar
  14. 14.
    Oshima, M, Dinchuk, JE, Kargman, SL 1996Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)Cell878039CrossRefPubMedGoogle Scholar
  15. 15.
    Iniguez, MA, Punzon, C, Fresno, M 1999Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitorsJ Immunol1631119PubMedGoogle Scholar
  16. 16.
    Zhang, F, Subbaramaiah, K, Altorki, N,  et al. 1998Dihydroxy bile acids activate the transcription of cyclooxygenase-2J Biol Chem27324248CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang, F, Altorki, NK, Wu, Y-C,  et al. 2001Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acidsGastroenterology12113919CrossRefPubMedGoogle Scholar
  18. 18.
    Glinghammar, B, Rafter, J 2001Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cellsGastroenterology12040110CrossRefPubMedGoogle Scholar
  19. 19.
    Chandrasekharan, NV, Dai, H, Roos, KL,  et al. 2002COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expressionProc Natl Acad Sci USA991392631CrossRefPubMedGoogle Scholar
  20. 20.
    Schlemper, RJ, Itabashi, M, Kato, Y,  et al. 1997Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologistsLancet34917259CrossRefPubMedGoogle Scholar
  21. 21.
    Buskens, CJ, van Rees, BP, Sivula, A,  et al. 2002Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of esophagusGastroenterology12218007CrossRefPubMedGoogle Scholar
  22. 22.
    van Rees, BP, Saukkonen, K, Ristimaki, A,  et al. 2002Cyclooxygenase-2 expression during carcinogenesis in the human stomachJ Pathol1961719CrossRefPubMedGoogle Scholar
  23. 23.
    Kawada, M, Seno, H, Wada, M,  et al. 2003Cyclooxygenase-2 expression and angiogenesis in gastric hyperplastic polyp—association with polyp sizeDigestion67204CrossRefPubMedGoogle Scholar
  24. 24.
    Yamashita, K, Arimura, Y, Shimizu, H,  et al. 2003Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors)J Gastroenterol386973CrossRefPubMedGoogle Scholar
  25. 25.
    Miwa, K, Fujimura, T, Hasegawa, H,  et al. 1992Is bile or are pancreaticoduodenal secretions related to gastric carcinogenesis in rats with reflux through the pylorušJ Cancer Res Clin Oncol1185704CrossRefPubMedGoogle Scholar
  26. 26.
    Romano, M, Vittorio, R, Memoli, A,  et al. 1998Helicobactor pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitroJ Biol Chem273285603CrossRefPubMedGoogle Scholar
  27. 27.
    Fu, S, Ramanujam, KS, Wong, A,  et al. 1999Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritisGastroenterology116131929PubMedGoogle Scholar
  28. 28.
    McCarthy, CJ, Crofford, LJ, Greenson, J,  et al. 1999Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infectionAm J Gastroenterol94121823CrossRefPubMedGoogle Scholar
  29. 29.
    Bamba, H, Ota, S, Kato, A,  et al. 1999High expression of cyclooxygenase-2 in macrophages on human colonic adenomaInt J Cancer834705CrossRefPubMedGoogle Scholar
  30. 30.
    Chapple, KS, Cartwright, EJ, Hawcrott, G,  et al. 2000Localization of cyclooxygenase-2 in human sporadic colorectal adenomasAm J Pathol15654553PubMedGoogle Scholar
  31. 31.
    Saukkonen, K, Rintahaka, J, Sivula, A,  et al. 2003Cyclooxygenase-2 and gastric carcinogenesisAPMIS11191525CrossRefPubMedGoogle Scholar
  32. 32.
    Guillem, JG, O’Brian, CA, Fitzer, CJ,  et al. 1987Studies on protein kinase C and colon carcinogenesisArch Surg12214758PubMedGoogle Scholar
  33. 33.
    Jones, BA, Rao, YP, Stravitz, RT,  et al. 1997Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase CAm J Physiol272G110915PubMedGoogle Scholar
  34. 34.
    Narumiya, S, Sugimoto, Y, Ushikubi, F 1999Prostanoid receptors: structures, properties, and functionsPhysiol Rev791193221PubMedGoogle Scholar
  35. 35.
    Pai, R, Soreghan, B, Szabo, IL,  et al. 2002Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophyNat Med828993CrossRefPubMedGoogle Scholar
  36. 36.
    Goodwin, JS 1989Immunomodulation by eicosanoids and anti-inflammatory drugsCurr Opin Immunol32648Google Scholar
  37. 37.
    Phipps, RP, Stein, SH, Roper, RL 1991A new view of prostaglandin E regulation of the immune responseImmunol Today1234952CrossRefPubMedGoogle Scholar
  38. 38.
    Tsujii, M, Kawano, S, Tsuji, S,  et al. 1998Cyclooxygenase regulates angiogenesis induced by colon cancer cellsCell9370516CrossRefPubMedGoogle Scholar
  39. 39.
    Pai, R, Szabo, IL, Soreghan, BA,  et al. 2001PGE2 stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathwayBiochem Biophys Res Commun2869238CrossRefPubMedGoogle Scholar
  40. 40.
    Tsujii, M, Dubois, RN 1995Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell83493501CrossRefPubMedGoogle Scholar
  41. 41.
    Li, M, Wu, X, Xu, XC 2001Induction of apoptosis by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway in esophageal cancer cellsInt J Cancer9321823CrossRefPubMedGoogle Scholar
  42. 42.
    Li, M, Wu, X, Xu, XC 2001Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathwayClin Cancer Res710106PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2005

Authors and Affiliations

  • Hiroshi Yasuda
    • 1
  • Masaya Yamada
    • 1
  • Yutaka Endo
    • 1
  • Kazuaki Inoue
    • 1
  • Makoto Yoshiba
    • 1
  1. 1.Division of GastroenterologyShowa University Fujigaoka HospitalYokohamaJapan

Personalised recommendations